Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S512000, C514S415000
Reexamination Certificate
active
11043213
ABSTRACT:
The present invention is directed to certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
REFERENCES:
patent: WO 97/141671 (1997-04-01), None
patent: WO 2005/032464 (2005-04-01), None
Co-pending U.S.Appl. No. 10/586,727, filed Jul. 18, 2006.
Bunda Jaime Lynn
DeVita Robert J.
Jiang Jinlong
Mills Sander G.
Coppins Janet L.
Gamara Valerie J.
Merck & Co. , Inc.
Thies J. Eric
Yuro Raynard
LandOfFree
Hydroisoindoline tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroisoindoline tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroisoindoline tachykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3778435